Pathogenic bacteria infection is a major public health problem due to the high morbidity and
mortality rates, as well as the increased expenditure on patient management. Although there …

The rapid emergence of drug resistance continues to outpace the development of new
antibiotics in the treatment of infectious diseases. Conventional therapy is currently limited …

For decades infections have been treated easily with drugs. However, in the 21st century,
they may become lethal again owing to the development of antimicrobial resistance …

Colloidal drug delivery systems have been extensively investigated as drug carriers for the
application of different drugs via different routes of administration. Systems, such as solid …

The rise of bacterial resistance to current antibiotics poses a threat to humanity and
reinforces the need for new-generation nanomaterials with antibacterial properties and …

Biofilms are matrix-enclosed communities of bacteria that show increased antibiotic
resistance and the capability to evade the immune system. They can cause recalcitrant …

Alexander Fleming's discovery of penicillin heralded an age of antibiotic development and
healthcare advances that are premised on the ability to prevent and treat bacterial infections …

Antibiotic therapy is the most powerful strategy for treating bacterial infections in clinic.
However, antibiotic resistance has become one of the biggest threats to public health …

Antibiotic resistance is a significant public health issue, causing illnesses that were once
easily treatable with antibiotics to develop into dangerous infections, leading to substantial …

Biofilm targeting represents a great challenge for effective antimicrobial therapy. Increased
biofilm resistance, even with the elevated concentrations of very potent antimicrobial agents …